Biotechnology - , ,
Alpha Cancer Technologies Inc. (ACT) is a private clinical stage biotechnology company with platform technologies in Immunotherapy and Immuno-Oncology. These platforms under development treat auto-immune disease indications and cancer. The company's drug products use our proprietary recombinant human alpha fetoprotein (AFP).
WordPress.org
Google Font API
Mobile Friendly
GoDaddy Hosting
Vimeo